Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|February 26, 2021
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIVGiovanni Guaraldi, Stefano Calza, Jovana Milic, et al.
Antibiotics (Basel, Switzerland)|July 27, 2024
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA CohortMarco Fois, Andrea De Vito, Francesca Cherchi, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2024
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Antonio Di Biagio, et al.
BMC Infectious Diseases|May 27, 2025
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI studyNicola Squillace, Elena Delfina Ricci, Giancarlo Orofino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2021
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational StudyMarco Franzetti, Andrea Forastieri, Noemi Borsa, et al.
Frontiers in Aging|November 24, 2025
Correction: Health profiles of foreign-born elderly women with HIV in ItalyStefania Arsuffi, Eugenia Quiros-Roldan, Fabio Riccardo Colombo, et al.
Frontiers in Aging|October 15, 2025
Health profiles of foreign-born elderly women with HIV in ItalyStefania Arsuffi, Eugenia Quiros-Roldan, Fabio Riccardo Colombo, et al.
Plos One|August 9, 2023
Real-life safety of Emtricitabine/Tenofovir Alafenamide/BictegravirNicola Squillace, Elena Ricci, Paolo Maggi, et al.
Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 14, 2026
Is less always more? Ceftazidime/avibactam alone or in combination to treat infections caused by Pseudomonas aeruginosa: a retrospective observational multi-centre cohort studyPietro Valsecchi, Marta Colaneri, Andrea Lombardi, et al.
Pageof 6